Label: MECLIZINE 25- meclizine hydrochloride tablet

  • NDC Code(s): 57963-101-01
  • Packager: The Generic Pharmaceutical Company
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated January 9, 2017

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Drug Facts

    Close
  • Active Ingredients (in each immediate-release tablet)

    Meclizine 25 mg

    Close
  • Purpose

    Antiemetic

    Close
  • Indications and Usage

    • For prevention and treatment of these symptoms associated with motion sickness:
      • nausea
      • vomiting
      • dizziness
    Close
  • Warnings

    • Do not use for children under 12 years of age unless directed by a doctor.

    Ask a doctor before use if you have

    • glaucoma
    • difficulty in urination due to enlargement of the prostate gland
    • a breathing problem such as emphysema or chronic bronchitis

    Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers

    When using this product

    • drowsiness may occur
    • avoid alcoholic drinks
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • be careful when driving a motor vehicle or operating machinery

    If pregnant or breast-feeding,

    • ask health professional before use.

    Keep out of reach of children.

    In case of accidental overdose, seek medical help or contact a Poison Control Center immediately. 1-800-222-1222

    Close
  • Directions

    Do not exceed recommended dosage.

    To prevent motion sickness; take the first dose one hour before starting activity.

    Adults and children 12 years of age and over: 1 to 2 tablets once daily, or as directed by a doctor.
    Close
  • Inactive ingredients

    Magnesium Stearate, Microcrystalline Cellulose, Sodium Starch Glycolate

    Close
  • Questions and comments?

    Call 1-205-313-8298

    Close
  • SPL UNCLASSIFIED SECTION

    Manufactured for
    The Generic Pharmaceutical Company, Inc.
    Leeds, AL 35094

    Close
  • PRINCIPAL DISPLAY PANEL - 25 mg Tablet Bottle Label

    NDC 57963-101-01
    100 Tablets

    Meclizine 25
    Antiemetic

    Each immediate-release tablet contains:
    Meclizine HCl
    25 mg

    Store at 59°-86°F (15°-30°C)
    [see USP Controlled Room Temperature].
    Tamper evident by foil seal under cap.
    Do not use if foil seal is broken or missing.

    Manufactured for
    The Generic Pharmaceutical Company, Inc.
    Leeds, AL 35094

    PRINCIPAL DISPLAY PANEL - 25 mg Tablet Bottle Label
    Close
  • INGREDIENTS AND APPEARANCE
    MECLIZINE 25 
    meclizine hydrochloride tablet
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:57963-101
    Route of Administration ORAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE 25 mg
    Inactive Ingredients
    Ingredient Name Strength
    Magnesium Stearate (UNII: 70097M6I30)  
    Microcrystalline Cellulose (UNII: OP1R32D61U)  
    SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  
    Product Characteristics
    Color WHITE Score no score
    Shape OVAL Size 13mm
    Flavor Imprint Code MC
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:57963-101-01 100 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 12/01/2016
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part336 12/01/2016
    Labeler - The Generic Pharmaceutical Company (078787060)
    Close